Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types

M Jovanovic, G Guterman-Ram, JC Marini - Endocrine reviews, 2022 - academic.oup.com
Osteogenesis imperfecta (OI) is a phenotypically and genetically heterogeneous skeletal
dysplasia characterized by bone fragility, growth deficiency, and skeletal deformity …

Osteogenesis imperfecta

JC Marini, WA Cabral - Genetics of bone biology and skeletal disease, 2018 - Elsevier
Osteogenesis imperfecta is a genetic disorder characterized by low bone mass, decreased
bone strength, increased bone fragility, and shortened stature. Autosomal dominant …

Severely impaired bone material quality in chihuahua zebrafish resembles classical dominant human osteogenesis imperfecta

IAK Fiedler, FN Schmidt, EM Wölfel… - Journal of Bone and …, 2018 - academic.oup.com
Excessive skeletal deformations and brittle fractures in the vast majority of patients suffering
from osteogenesis imperfecta (OI) are a result of substantially reduced bone quality …

[PDF][PDF] The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta

R Gioia, F Tonelli, I Ceppi, M Biggiogera… - Human molecular …, 2017 - academic.oup.com
Classical osteogenesis imperfecta (OI) is a bone disease caused by type I collagen
mutations and characterized by bone fragility, frequent fractures in absence of trauma and …

New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review

A Dinulescu, AS Păsărică, M Carp, A Dușcă… - Journal of Clinical …, 2024 - mdpi.com
(1) Background: Osteogenesis imperfecta (OI) is a rare skeletal dysplasia characterized as a
heterogeneous disorder group with well-defined phenotypic and genetic features that share …

A Novel High-Throughput Screening Platform Identifies Itaconate Derivatives from Marine Penicillium antarcticum as Inhibitors of Mesenchymal Stem Cell …

P Marchese, N Mahajan, E O'Connell, H Fearnhead… - Marine Drugs, 2020 - mdpi.com
Worldwide diffused diseases such as osteoarthritis, atherosclerosis or chronic kidney
disease are associated with a tissue calcification process which may involve unexpected …

Clinical trials in skeletal dysplasia: A paradigm for treating rare diseases

A Sabir, M Irving - British medical bulletin, 2021 - academic.oup.com
Background Genetic skeletal dysplasia conditions (GSDs) account for 5% of all birth defects.
Until recently, targeted treatments were only available for select few conditions; however …

Gene Therapy in Pediatric Orthopedics

E Olaonipekun, A Lisyansky, R Olaonipekun… - Osteology, 2024 - mdpi.com
Gene therapy is gaining traction as an effective treatment for several deleterious disorders
by delivering genetic material using viral or non-viral vectors to correct mutated genes …

Heritable skeletal disorders arising from defects in processing and transport of type I procollagen from the ER: perspectives on possible therapeutic approaches

MB Cutrona, NE Morgan, JC Simpson - Targeting trafficking in drug …, 2018 - Springer
Rare bone disorders are a heterogeneous group of diseases, initially associated with
mutations in type I procollagen (PC) genes. Recent developments from dissection at the …

[PDF][PDF] O Caso das Doenças Raras

J Sá - Medicina Interna, 2022 - revista.spmi.pt
O Caso das Doenças Raras The Rare Diseases Issue Page 1 EDITORIAL EDITORIAL 82
Medicina Interna REVISTA DA SOCIEDADE PORTUGUESA DE MEDICINA INTERNA O …